Innovent and IASO Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting

SAN FRANCISCO, U.S. and SUZHOU, China: SAN FRANCISCO, U.S. and SUZHOU, China, Dec. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, and IASO Biotherapeutics ("IASO Bio"),...

Click to view original post